M. Perry
Publications by Year
Research Areas
Lung Cancer Research Studies, Lung Cancer Treatments and Mutations, HIV/AIDS Research and Interventions, HIV Research and Treatment, Lung Cancer Diagnosis and Treatment
Most-Cited Works
- → Once-Weekly Dalbavancin versus Standard-of-Care Antimicrobial Regimens for Treatment of Skin and Soft-Tissue Infections(2003)233 cited
- → Prospective randomized trial of postoperative adjuvant therapy in patients with completely resected stages II and IIIa non-small cell lung cancer: An intergroup trial (E3590)(2000)21 cited
- → Thyroid function in patients with breast cancer.(1978)17 cited
- → Efficacy and safety of patupilone in non-small cell lung cancer (NSCLC): A phase I/II trial(2006)16 cited
- → Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012–2018(2021)12 cited
- → Low-level viral loads and virological failure in the integrase strand transfer era(2023)9 cited
- Phase II trial of amsacrine in patients with hepatoma: a Cancer and Leukemia Group B study.(1984)
- → Drastic Reduction in Time to Controlled Viral Load in People With Human Immunodeficiency Virus in France, 2009–2019: A Longitudinal Cohort Study(2023)5 cited
- → O-088 Phase III randomized trial comparing weekly vs. standard schedules of paclitaxel (P) plus carboplatin (C) for advanced non-small cell lung cancer (NSCLC): Analyses of elderly patients(2005)4 cited
- → O-093 Meta-analysis of weekly paclitaxel as maintenance therapy foradvanced non-small cell lung cancer (NSCLC) patients following intitial chemotherapy(2005)2 cited